PHARMACOKINETICS OF CEFOPERAZONE (2.0 G) AND SULBACTAM (1.0 G) COADMINISTERED TO SUBJECTS WITH NORMAL RENAL-FUNCTION, PATIENTS WITH DECREASED RENAL-FUNCTION, AND PATIENTS WITH END-STAGE RENAL-DISEASE ON HEMODIALYSIS

被引：32

作者：

REITBERG, DP

MARBLE, DA

SCHULTZ, RW

WHALL, TJ

SCHENTAG, JJ

机构：

[1] SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,BUFFALO,NY 14260

[2] PFIZER INC,DEPT CLIN & SCI AFFAIRS,NEW YORK,NY 10017

[3] SUNY BUFFALO,SCH PHARM,DIV CLIN PHARM SCI,BUFFALO,NY 14260

[4] MILLARD FILLMORE HOSP,DEPT MED,BUFFALO,NY 14209

[5] MILLARD FILLMORE HOSP,CLIN PHARMACOKINET LAB,BUFFALO,NY 14209

[6] PFIZER INC,DIV QUAL CONTROL,GROTON,CT 06340

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1988年 / 32卷 / 04期

关键词：

D O I：

10.1128/AAC.32.4.503

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：503 / 509

页数：7

共 19 条

[1]

BALANT L, 1980, CLIN THER, V3, P50

[2] PHARMACOKINETICS OF CEFOPERAZONE IN NORMAL VOLUNTEERS AND SUBJECTS WITH RENAL-INSUFFICIENCY [J].

BOLTON, WK ;

SCHELD, WM ;

SPYKER, DA ;

SANDE, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (05) :821-825

[3] COMPARATIVE PHARMACOKINETICS AND TISSUE PENETRATION OF SULBACTAM AND AMPICILLIN AFTER CONCURRENT INTRAVENOUS ADMINISTRATION [J].

BROWN, RM ;

WISE, R ;

ANDREWS, JM ;

HANCOX, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :565-567

[4]

COCKCROFT DW, 1976, NEPHROLOGIE, V16, P34

[5]

CRAIG WA, 1980, CLIN THER, V3, P46

[6] GENTAMICIN THERAPY [J].

DEVINE, BJ .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11) :650-655

[7] CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION [J].

ENGLISH, AR ;

RETSEMA, JA ;

GIRARD, AE ;

LYNCH, JE ;

BARTH, WE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) :414-419

[8] PHARMACOKINETICS OF SULBACTAM IN HUMANS [J].

FOULDS, G ;

STANKEWICH, JP ;

MARSHALL, DC ;

OBRIEN, MM ;

HAYES, SL ;

WEIDLER, DJ ;

MCMAHON, FG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :692-699

[9]

GIBALDI M, 1982, PHARMACOKINETICS

[10]

GREENFIELD RA, 1983, REV INFECT DIS, V5, pS127

← 1 2 →